Advertisement
Review article| Volume 98, ISSUE 5, P1004-1017.e1, May 2017

Quality of Life and Psychosocial Well-Being in Youth With Neuromuscular Disorders Who Are Wheelchair Users: A Systematic Review

Published:November 10, 2016DOI:https://doi.org/10.1016/j.apmr.2016.10.011

      Highlights

      • Some groups of youth with neuromuscular disorders on degenerative disease trajectories and in different countries report lower psychosocial quality of life, but not significantly, compared with typically developing peers.
      • Challenges to identify formation and body image may compromise well-being in younger adolescents with Duchenne muscular dystrophy, but changes over time in the same population are not known.
      • Information about mental health and social participation in youth with neuromuscular disorders is currently restricted to those cared for in specialist clinics and cannot be compared with other populations.

      Abstract

      Objective

      To investigate quality of life (QOL) and psychosocial well-being in youth with neuromuscular disorders (NMDs) who are wheelchair users.

      Data Sources

      MEDLINE, Embase, CINAHL, and PsycINFO (January 2004–April 2016) and reference lists of retrieved full-text articles.

      Study Selection

      Peer-reviewed studies were included when data describing self-reported QOL and psychosocial well-being could be separately understood for those using wheelchairs and 12 to 22 years of age. There were 2058 records independently screened, and potentially eligible articles were obtained and examined by all reviewers. Twelve observational and 3 qualitative studies met the inclusion criteria.

      Data Extraction

      Population representativeness, measurement tools, and outcomes, where possible, with comparison groups. Two reviewers independently appraised studies for risk of bias to internal validity and generalizability.

      Data Synthesis

      Heterogeneity of measurement and reporting precluded meta-analysis. Data were cross-sectional only. Compared with same-age typically developing peers, physical QOL was scored consistently and significantly lower in youth with NMDs, whereas psychosocial QOL was not. Psychosocial QOL was highest in youth nonambulant since early childhood and in those recruited via single tertiary specialist clinics. Mental health and social participation could not be compared with same-age populations.

      Conclusions

      Despite low physical QOL, psychosocial QOL in youth with NMDs appeared comparable with same-age peers. The psychosocial well-being of younger adolescents on degenerative disease trajectories appeared most compromised; however, the longitudinal effects of growing up with a NMD on mental health and social participation are unknown. Interpretation was hampered by poor description of participant age, sex and physical ability; lack of population-based recruitment strategies; and inconsistent use of age-appropriate measures. Understanding of self-reported QOL and psychosocial well-being in youth with NMDs transitioning to adulthood is limited.

      Keywords

      List of abbreviations:

      DMD (Duchenne muscular dystrophy), NIV (Noninvasive ventilation), NMD (Neuromuscular disorder), PedsQL (Pediatric Quality of Life Inventory), QOL (Quality of life), SF-36 (Medical Outcomes Study 36-Item Short-Form Health Survey)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Archives of Physical Medicine and Rehabilitation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. European Commission. Rare diseases – what are they? 2013. Available at: http://ec.europa.eu/health/rare_diseases/policy/index_en.htm. Accessed April, 12 2014.

        • Tawil R.
        • Venance S.
        Neuromuscular disorders.
        Wiley, Hoboken2011
        • Werlauff U.
        • Vissing J.
        • Steffensen B.F.
        Change in muscle strength over time in spinal muscular atrophy types II and III. A long-term follow-up study.
        Neuromuscul Disord. 2012; 22: 1069-1074
        • Bushby K.
        • Finkel R.
        • Birnkrant D.J.
        • et al.
        Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.
        Lancet Neurol. 2010; 9: 77-93
        • Cotton S.M.
        • Voudouris N.J.
        • Greenwood K.M.
        Association between intellectual functioning and age in children and young adults with Duchenne muscular dystrophy: further results from a meta-analysis.
        Dev Med Child Neurol. 2005; 47: 257-265
        • Wang C.H.
        • Finkel R.S.
        • Bertini E.S.
        • et al.
        Consensus statement for standard of care in spinal muscular atrophy.
        J Child Neurol. 2007; 22: 1027-1049
        • Wang C.H.
        • Dowling J.J.
        • North K.
        • et al.
        Consensus statement on standard of care for congenital myopathies.
        J Child Neurol. 2012; 27: 363-382
        • Bushby K.
        • Finkel R.
        • Birnkrant D.J.
        • et al.
        Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.
        Lancet Neurol. 2010; 9: 177-189
        • Hull J.
        • Aniapravan R.
        • Chan E.
        • et al.
        British Thoracic Society guideline for respiratory management of children with neuromuscular weakness.
        Thorax. 2012; 67: i1-i40
        • Bach J.R.
        • Martinez D.
        Duchenne muscular dystrophy: continuous noninvasive ventilatory support prolongs survival.
        Respir Care. 2011; 56: 744-750
        • Ishikawa Y.
        • Miura T.
        • Ishikawa Y.
        • et al.
        Duchenne muscular dystrophy: survival by cardio-respiratory interventions.
        Neuromuscul Disord. 2011; 21: 47-51
        • Gibson B.E.
        • Zitzelsberger H.
        • McKeever P.
        ‘Futureless persons’: shifting life expectancies and the vicissitudes of progressive illness.
        Sociol Health Illn. 2009; 31: 554-568
        • Pangalila R.
        • van den Bos G.A.
        • Bartels B.
        • et al.
        Quality of life of adult men with Duchenne muscular dystrophy in the Netherlands: implications for care.
        J Rehabil Med. 2015; 47: 161-166
        • Rahbek J.
        • Werge B.
        • Madsen A.
        • Marquardt J.
        • Steffensen B.F.
        • Jeppesen J.
        Adult life with Duchenne muscular dystrophy: observations among an emerging and unforeseen patient population.
        Pediatr Rehabil. 2005; 8: 17-28
        • van Huijzen S.
        • van Staa A.
        Chronic ventilation and social participation: experiences of men with neuromuscular disorders.
        Scand J Occup Ther. 2013; 20: 209-216
        • Hamilton M.J.
        • Longman C.
        • O'Hara A.
        • Kirkpatrick M.
        • McWilliam R.
        Growing up with spinal muscular atrophy with respiratory distress (SMARD1).
        Neuromuscul Disord. 2015; 25: 169-171
        • Weinberg M.
        • Tomyn A.
        Community survey of young Victorians' resilience and mental wellbeing. Full report: part A and part B.
        Victorian Health Promotion Foundation, Melbourne2015
        • Gore F.M.
        • Bloem P.J.
        • Patton G.C.
        • et al.
        Global burden of disease in young people aged 10–24 years: a systematic analysis.
        Lancet. 2011; 377: 2093-2102
        • Abbott D.
        • Carpenter J.
        • Bushby K.
        Transition to adulthood for young men with Duchenne muscular dystrophy: research from the UK.
        Neuromuscul Disord. 2012; 22: 445-446
        • Maslow G.R.
        • Chung R.J.
        Systematic review of positive youth development programs for adolescents with chronic illness.
        Pediatrics. 2013; 131: e1605-e1618
        • Sawyer S.M.
        • Ambresin A.E.
        Successful transitions: beyond disease control to better life chances.
        J Adolesc Health. 2014; 54: 365-366
        • Amin R.
        • Al-Saleh S.
        • Narang I.
        Domiciliary noninvasive positive airway pressure therapy in children.
        Pediatr Pulmonol. 2016; 51: 335-348
        • Prashad P.S.
        • Marcus C.L.
        • Maggs J.
        • et al.
        Investigating reasons for CPAP adherence in adolescents: a qualitative approach.
        J Clin Sleep Med. 2013; 9: 1303-1313
        • Ward S.
        • Chatwin M.
        • Heather S.
        • Simonds A.K.
        Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia.
        Thorax. 2005; 60: 1019-1024
        • Rousseau M.C.
        • Pietra S.
        • Blaya J.
        • Catala A.
        Quality of life of ALS and LIS patients with and without invasive mechanical ventilation.
        J Neurol. 2011; 258: 1801-1804
        • Katz S.L.
        • Gaboury I.
        • Keilty K.
        • et al.
        Nocturnal hypoventilation: predictors and outcomes in childhood progressive neuromuscular disease.
        Arch Dis Child. 2010; 95: 998-1003
        • Mah J.K.
        • Thannhauser J.E.
        • McNeil D.A.
        • Dewey D.
        Being the lifeline: the parent experience of caring for a child with neuromuscular disease on home mechanical ventilation.
        Neuromuscul Disord. 2008; 18: 983-988
        • Sawyer S.M.
        • Drew S.
        • Yeo M.S.
        • Britto M.T.
        Adolescents with a chronic condition: challenges living, challenges treating.
        Lancet. 2007; 369: 1481-1489
        • Hultman L.
        • Forinder U.
        • Pergert P.
        Assisted normality–a grounded theory of adolescent's experiences of living with personal assistance.
        Disabil Rehabil. 2016; 38: 1053-1062
        • Coverdale G.E.
        • Long A.F.
        Emotional wellbeing and mental health: an exploration into health promotion in young people and families.
        Perspect Public Health. 2015; 135: 27-36
        • Landfeldt E.
        • Lindgren P.
        • Bell C.F.
        • et al.
        Health-related quality of life in patients with Duchenne muscular dystrophy: a multinational, cross-sectional study.
        Dev Med Child Neurol. 2016; 58: 508-515
        • Bray P.
        • Bundy A.C.
        • Ryan M.M.
        • North K.N.
        • Burns J.
        Health status of boys with Duchenne muscular dystrophy: a parent's perspective.
        J Paediatr Child Health. 2011; 47: 557-562
        • Moher D.
        • Shamseer L.
        • Clarke M.
        • et al.
        Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.
        Syst Rev. 2015; 4: 1
        • Clark R.
        • Locke M.
        • Bialocerkowski A.
        Paediatric terminology in the Australian health and health-education context: a systematic review.
        Dev Med Child Neurol. 2015; 57: 1011-1018
      2. Higgins J, Green S. The Cochrane Collaboration's tool for assessing risk of bias. Section 8.5.3. Available at: http://training.cochrane.org/handbook. Accessed July 12, 2016.

        • Shamliyan T.
        • Kane R.L.
        • Dickinson S.
        A systematic review of tools used to assess the quality of observational studies that examine incidence or prevalence and risk factors for diseases.
        J Clin Epidemiol. 2010; 63: 1061-1070
        • Shields N.
        • Taylor N.F.
        • Dodd K.J.
        Self-concept in children with spina bifida compared with typically developing children.
        Dev Med Child Neurol. 2008; 50: 733-743
        • Hoy D.
        • Brooks P.
        • Woolf A.
        • et al.
        Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement.
        J Clin Epidemiol. 2012; 65: 934-939
      3. von Elm E, Altman D, Egger M, et al. STROBE checklists for cohort, case-control and cross-sectional studies. ISPM University of Bern. Available at: http://www.strobe-statement.org/index.php?id=available-checklists. Accessed August 3, 2015.

        • Janssen M.M.
        • Bergsma A.
        • Geurts A.C.
        • De Groot I.J.
        Patterns of decline in upper limb function of boys and men with DMD: an international survey.
        J Neurol. 2014; 261: 1269-1288
        • Bray P.
        • Bundy A.C.
        • Ryan M.M.
        • North K.N.
        • Everett A.
        Health-related quality of life in boys with Duchenne muscular dystrophy: agreement between parents and their sons.
        J Child Neurol. 2010; 25: 1188-1194
        • Parkyn H.
        • Coveney J.
        An exploration of the value of social interaction in a boys' group for adolescents with muscular dystrophy.
        Child Care Health Dev. 2013; 39: 81-89
        • Young H.K.
        • Lowe A.
        • Fitzgerald D.A.
        • et al.
        Outcome of noninvasive ventilation in children with neuromuscular disease.
        Neurology. 2007; 68: 198-201
        • Davis S.E.
        • Hynan L.S.
        • Limbers C.A.
        • et al.
        The PedsQL in pediatric patients with duchenne muscular dystrophy: Feasibility, reliability, and validity of the pediatric quality of life inventory neuromuscular module and generic core scales.
        J Clin Neuromuscul Dis. 2010; 11: 97-109
        • Pehler S.R.
        • Craft-Rosenberg M.
        Longing: the lived experience of spirituality in adolescents with Duchenne muscular dystrophy.
        J Pediatr Nurs. 2009; 24: 481-494
        • Uzark K.
        • King E.
        • Cripe L.
        • et al.
        Health-related quality of life in children and adolescents with Duchenne muscular dystrophy.
        Pediatrics. 2012; 130: e1559-e1566
        • Elsenbruch S.
        • Schmid J.
        • Lutz S.
        • Geers B.
        • Schara U.
        Self-reported quality of life and depressive symptoms in children, adolescents, and adults with Duchenne muscular dystrophy: a cross-sectional survey study.
        Neuropediatrics. 2013; 44: 257-264
        • Hamdani Y.
        • Mistry B.
        • Gibson B.E.
        Transitioning to adulthood with a progressive condition: best practice assumptions and individual experiences of young men with Duchenne muscular dystrophy.
        Disabil Rehabil. 2015; 37: 1144-1151
        • Kohler M.
        • Clarenbach C.F.
        • Boni L.
        • Brack T.
        • Russi E.W.
        • Bloch K.E.
        Quality of life, physical disability, and respiratory impairment in Duchenne muscular dystrophy.
        Am J Respirat Crit Care Med. 2005; 172: 1032-1036
        • Read J.
        • Simonds A.
        • Kinali M.
        • Muntoni F.
        • Garralda M.E.
        Sleep and well-being in young men with neuromuscular disorders receiving non-invasive ventilation and their carers.
        Neuromuscul Disord. 2010; 20: 458-463
        • Simon V.A.
        • Dutra Resende M.B.
        • Simon M.A.
        • Zanoteli E.
        • Reed U.C.
        Duchenne muscular dystrophy: quality of life in 95 patients evaluated by the Life Satisfaction Index for Adolescents.
        Arq Neuropsiquiatr. 2011; 69: 19-22
        • Suk K.S.
        • Baek J.H.
        • Park J.O.
        • et al.
        Postoperative quality of life in patients with progressive neuromuscular scoliosis and their parents.
        Spine J. 2015; 15: 446-453
        • Vuillerot C.
        • Hodgkinson I.
        • Bissery A.
        • et al.
        Self-perception of quality of life by adolescents with neuromuscular diseases.
        J Adolesc Health. 2010; 46: 70-76
        • Grootenhuis M.A.
        • de Boone J.
        • van der Kooi A.J.
        Living with muscular dystrophy: health related quality of life consequences for children and adults.
        Health Qual Life Outcomes. 2007; 5: 31
        • Imms C.
        • Adair B.
        • Keen D.
        • Ullenhag A.
        • Rosenbaum P.
        • Granlund M.
        ‘Participation’: a systematic review of language, definitions, and constructs used in intervention research with children with disabilities.
        Dev Med Child Neurol. 2016; 58: 29-38
        • Bann C.M.
        • Abresch R.T.
        • Biesecker B.
        • et al.
        Measuring quality of life in muscular dystrophy.
        Neurology. 2015; 84: 1034-1042
        • Pangalila R.
        Quality of life in Duchenne muscular dystrophy: the disability paradox.
        Dev Med Child Neurol. 2016; 58: 435-436
        • Chamova T.
        • Guergueltcheva V.
        • Raycheva M.
        • et al.
        Association between loss of Dp140 and cognitive impairment in Duchenne and Becker dystrophies.
        Balkan J Med Genet. 2013; 16: 21-30
        • Mochizuki H.
        • Miyatake S.
        • Suzuki M.
        • et al.
        Mental retardation and lifetime events of Duchenne muscular dystrophy in Japan.
        Intern Med. 2008; 47: 1207-1210
        • Sawyer S.M.
        • Afifi R.A.
        • Bearinger L.H.
        • et al.
        Adolescence: a foundation for future health.
        Lancet. 2012; 379: 1630-1640
        • Wood C.L.
        • Straub V.
        • Guglieri M.
        • Bushby K.
        • Cheetham T.
        Short stature and pubertal delay in Duchenne muscular dystrophy.
        Arch Dis Child. 2016; 101: 101-106
        • Skrove M.
        • Lydersen S.
        • Indredavik M.S.
        Resilience factors may moderate the associations between pubertal timing, body mass and emotional symptoms in adolescence.
        Acta Paediatr. 2016; 105: 96-104
        • Mission Australia, Black Dog Institute
        Young people's mental health over the years. Youth Survey 2012-2014.
        Mission Australia, Sydney, Australia2015
        • Landfeldt E.
        • Lindgren P.
        • Bell C.F.
        • et al.
        Quantifying the burden of caregiving in Duchenne muscular dystrophy.
        J Neurol. 2016; 263: 906-915
        • Powrie B.
        • Kolehmainen N.
        • Turpin M.
        • Ziviani J.
        • Copley J.
        The meaning of leisure for children and young people with physical disabilities: a systematic evidence synthesis.
        Dev Med Child Neurol. 2015; 57: 993-1010
        • Carter E.W.
        • Asmus J.
        • Moss C.K.
        • et al.
        Randomized evaluation of peer support arrangements to support the inclusion of high school students with severe disabilities.
        Except Child. 2016; 82: 209-233
        • Meehan E.
        • Harvey A.
        • Reid S.M.
        • et al.
        Therapy service use in children and adolescents with cerebral palsy: an Australian perspective.
        J Paediatr Child Health. 2016; 52: 308-314
        • Landfeldt E.
        • Lindgren P.
        • Bell C.F.
        • et al.
        Compliance to care guidelines for Duchenne muscular dystrophy.
        J Neuromuscul Dis. 2015; 2: 63-72
        • Lim Y.
        • Velozo C.
        • Bendixen R.M.
        The level of agreement between child self-reports and parent proxy-reports of health-related quality of life in boys with Duchenne muscular dystrophy.
        Qual Life Res. 2014; 23: 1945-1952
        • Di Filippo T.
        • Parisi L.
        • Roccella M.
        Psychological aspects in children affected by duchenne de boulogne muscular dystrophy.
        Ment Illn. 2012; 4: 21-24
        • Huismann D.J.
        • Sheldon J.P.
        • Yashar B.M.
        • Amburgey K.
        • Dowling J.J.
        • Petty E.M.
        Quality of life and autonomy in emerging adults with early-onset neuromuscular disorders.
        J Genet Couns. 2012; 21: 713-725
        • Rosenbaum P.L.
        • Palisano R.J.
        • Bartlett D.J.
        • Galuppi B.E.
        • Russell D.J.
        Development of the Gross Motor Function Classification System for cerebral palsy.
        Dev Med Child Neurol. 2008; 50: 249-253
        • Bushby K.
        • Connor E.
        Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings.
        Clin Investig (Lond). 2011; 1: 1217-1235
        • Janssens A.
        • Rogers M.
        • Gumm R.
        • et al.
        Measurement properties of multidimensional patient-reported outcome measures in neurodisability: a systematic review of evaluation studies.
        Dev Med Child Neurol. 2016; 58: 437-451
        • Ravens-Sieberer U.
        • Devine J.
        • Bevans K.
        • et al.
        Subjective well-being measures for children were developed within the PROMIS project: presentation of first results.
        J Clin Epidemiol. 2014; 67: 207-218
        • Orcesi S.
        • Ariaudo G.
        • Mercuri E.
        • Beghi E.
        • Rezzani C.
        • Balottin U.
        A new self-report quality of life questionnaire for children with neuromuscular disorders: presentation of the instrument, rationale for its development, and some preliminary results.
        J Child Neurol. 2014; 29: 167-181
        • Carter B.
        • Qualter P.
        • Dix J.
        Social relationships, loneliness and adolescence: the potential for disruption by chronic illness.
        J Child Health Care. 2015; 19: 421-422